Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region

被引:0
|
作者
Ayad, Nasrat M. [1 ]
Fattah, Waleed A. [2 ]
Bakry, Hani [2 ]
机构
[1] Taiba Hosp, Dept Internal Med, Kuwait, Kuwait
[2] Novo Nordisk Gulf, Dept Med, Riyadh, Saudi Arabia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:919 / 920
页数:2
相关论文
共 50 条
  • [1] Biphasic insulin aspart 30 improves postprandial glycemic control
    Hermansen, K
    Vaaler, S
    Madsbad, S
    Dalgaard, M
    Begtrup, K
    Lindholm, A
    DIABETES, 2001, 50 : A95 - A95
  • [2] Biphasic Insulin Aspart 30 (BIAsp 30) Improves Glycemic Control in Patients with Type 2 Diabetes Regardless of Previous Treatment Regimens: The IMPROVE Study in Iran
    Esteghamati, Alireza
    Rajabian, Reza
    Amini, Masoud
    Bahrami, Amir
    Khamseh, Mohammad Ebrahim
    Ardekani, Mohammad
    Rizi, Ehsan Parvaresh
    DIABETES, 2009, 58 : A516 - A516
  • [3] Significant improvements in glycemic control with biphasic insulin aspart 30 treatment among type 2 diabetes patients:: PRESENT study preliminary results
    Gueler, Serdar
    Tuna, Sebnem
    Shinde, Anil
    Lee, So Ra
    Lebedev, Nikolay
    Keduang, Timothy
    Hassan, Ayman
    Yeo, Jing Ping
    Yap, Charlotte
    DIABETES, 2007, 56 : A565 - A566
  • [4] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 Diabetes
    Esteghamati, Alireza
    Nakhjavani, Manouchehr
    Aminorroaya, Ashraf
    Aboutorabi, Robabeh
    Niafar, Mitra
    Mohammadi, Mohammad
    Parvaresh, Ehsan
    JOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)
  • [5] Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes
    M. Velojic-Golubovic
    D. Mikic
    M. Pesic
    D. Dimic
    S. Radenkovic
    S. Antic
    Journal of Endocrinological Investigation, 2009, 32 : 23 - 27
  • [6] Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes
    Velojic-Golubovic, M.
    Mikic, D.
    Pesic, M.
    Dimic, D.
    Radenkovic, S.
    Antic, S.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (01) : 23 - 27
  • [7] Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes
    Hermansen, K
    Vaaler, S
    Madsbad, S
    Dalgaard, M
    Zander, M
    Begtrup, K
    Soendergaard, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07): : 896 - 900
  • [8] Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes
    Hermansen, K
    Colombo, M
    Storgaard, H
    Ostergaard, A
    Kolendorf, K
    Madsbad, S
    DIABETES CARE, 2002, 25 (05) : 883 - 888
  • [9] Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study
    Gao, Y.
    Guo, X. H.
    Vaz, J. A.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 33 - 40
  • [10] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
    Valensi, Paul
    DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71